NPI: 1487607792 · LUFKIN, TX 75904 · Ambulatory Surgical Clinic/Center · NPI assigned 05/18/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 05/18/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 1,961 | $113K |
| 2021 | 17,010 | $942K |
| 2022 | 26,746 | $1.50M |
| 2023 | 30,069 | $2.13M |
| 2024 | 16,093 | $1.13M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 13,454 | 12,751 | $1.90M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 7,457 | 6,994 | $1.67M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6,687 | 6,401 | $410K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,383 | 3,256 | $319K |
| 71045 | Radiologic examination, chest; single view | 2,390 | 2,265 | $223K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,345 | 3,148 | $216K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,506 | 5,254 | $194K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,570 | 3,435 | $121K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 718 | 672 | $104K |
| 80053 | Comprehensive metabolic panel | 7,223 | 6,473 | $98K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 7,882 | 7,123 | $75K |
| 71046 | Radiologic examination, chest; 2 views | 439 | 430 | $56K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,169 | 910 | $54K |
| 86756 | 1,151 | 1,110 | $48K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2,481 | 2,138 | $44K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 393 | 373 | $43K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 142 | 123 | $25K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 81 | 79 | $25K |
| 70450 | Computed tomography, head or brain; without contrast material | 436 | 412 | $24K |
| 81001 | 5,130 | 4,694 | $21K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 786 | 753 | $14K |
| 81025 | 1,025 | 965 | $13K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 74 | 72 | $12K |
| 83735 | 1,537 | 1,379 | $9K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 132 | 111 | $8K |
| 83690 | 999 | 917 | $7K | |
| 84484 | 1,091 | 826 | $7K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 270 | 259 | $6K |
| 85027 | 805 | 731 | $5K | |
| 76818 | 28 | 24 | $5K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 183 | 148 | $5K |
| 87340 | 226 | 222 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 715 | 632 | $4K |
| 74018 | 29 | 26 | $4K | |
| 87634 | 25 | 25 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 875 | 826 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 15 | 13 | $3K |
| CP007 | 68 | 55 | $3K | |
| 81003 | 909 | 865 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 355 | 340 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,535 | 1,384 | $2K |
| G0378 | Hospital observation service, per hour | 14 | 13 | $2K |
| 83880 | 102 | 95 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 25 | 24 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 29 | 27 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 29 | 27 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 864 | 780 | $2K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 215 | 176 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 550 | 498 | $1K |
| 86850 | 103 | 100 | $1K | |
| 59025 | Fetal non-stress test | 15 | 14 | $1K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 356 | 289 | $1K |
| 86592 | 102 | 100 | $829.83 | |
| 84702 | 43 | 38 | $782.21 | |
| 85610 | 495 | 459 | $736.42 | |
| 86900 | 232 | 219 | $711.39 | |
| 83498 | 20 | 17 | $694.84 | |
| 86901 | 232 | 219 | $688.18 | |
| 85730 | 305 | 279 | $561.01 | |
| 83789 | 20 | 17 | $554.91 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 14 | 13 | $533.01 |
| 80306 | 15 | 14 | $463.41 | |
| 82261 | 20 | 17 | $431.42 | |
| 83605 | 71 | 57 | $380.92 | |
| 83520 | 20 | 17 | $372.11 | |
| 83020 | 20 | 17 | $329.27 | |
| 82776 | 20 | 17 | $270.14 | |
| 84437 | 20 | 17 | $165.53 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 242 | 230 | $112.70 |
| J1170 | Injection, hydromorphone, up to 4 mg | 52 | 41 | $103.06 |
| 86308 | 12 | 12 | $68.68 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 717 | 640 | $63.18 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 215 | 207 | $63.14 |
| 80061 | Lipid panel | 13 | 12 | $46.87 |
| 87186 | 13 | 12 | $29.42 | |
| 82550 | 13 | 13 | $18.84 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 14 | 13 | $17.63 |
| 85379 | 14 | 14 | $15.54 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 73 | 68 | $13.71 |
| 36415 | Collection of venous blood by venipuncture | 914 | 777 | $13.08 |
| 96375 | Therapeutic injection; each additional sequential IV push | 168 | 157 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 355 | 336 | $0.00 |
| 82962 | 325 | 171 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 41 | 39 | $0.00 |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | 28 | 28 | $0.00 |